Anika Therapeutics, Inc. (ANIK)
15.31
-0.54
(-3.41%)
USD |
NASDAQ |
Apr 28, 16:00
15.31
0.00 (0.00%)
After-Hours: 19:28
Anika Therapeutics EPS Diluted (Quarterly) : 0.0199 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BioCryst Pharmaceuticals, Inc. | 1.121 |
| Masimo Corp. | 1.311 |
| Lantheus Holdings, Inc. | 0.8156 |
| Evolus, Inc. | 0.002 |
| TELA Bio, Inc. | -0.1749 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.801M |
| Revenue (Quarterly) | 30.62M |
| Total Expenses (Quarterly) | 28.81M |
| Enterprise Value | 181.17M |
| Gross Profit Margin (Quarterly) | 62.65% |
| Profit Margin (Quarterly) | 5.88% |
| Earnings Yield | -4.96% |
| Normalized Earnings Yield | -4.956 |